Added to YB: 2022-02-28
Pitch date: 2022-02-28
IPA [bullish]
ImmunoPrecise Antibodies Ltd.
-63.02%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
ImmunoPrecise Antibodies Ltd. operates as a techbio company. It leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies; and support the discovery and development of therapeutic antibodies.
Market Cap
$110.2M
Pitch Price
$4.84
Price Target
N/A
Dividend
N/A
EV/EBITDA
-10.38
P/E
-1.48
EV/Sales
4.59
Sector
Life Sciences Tools and Services
Category
N/A
Show full summary:
IMMUNOPRECISE ANTIBODIES LTD IPA
A summary for this pitch has not been created yet.
Read full article (0 min)